A recent study also identified LRP1B, which encodes low-density lipoprotein receptor-related protein 1B, as a novel tumor suppressor, and LRP1B deletion was associated with chemotherapy resistance in ovarian cancer [44]. This evidence concerns the gene LRP1B and ovarian carcinoma.